Finding patients can look like an insurmountable challenge for companies working to bring therapies for rare conditions to market. Especially early on and without a proper team in place, biotech’s can struggle.  At the same time, boards will pressure the commercial team to produce results to justify confidence in the commercial viability of a program.  The good news is, Magnolia Innovation and 81qd are happy to help.  The attached one pager highlights how their team of market researchers, data analysts and consultants can support building out a patient finding strategy tailored to your team’s needs.  The case study covers several projects that combined consulting expertise, primary research, and data analytics.